Plain-English translation of NCT05788744 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether special blood tests can better predict which pancreatic cancer patients will benefit from surgery and whether these blood tests can catch cancer recurrence earlier than standard methods. The study has two parts: one where patients simply provide blood samples at key time points, and another where some patients receive follow-up care guided by these blood test results while others receive standard monitoring.
Pancreatic cancer can come back even after successful surgery, and doctors currently have limited ways to catch recurrence early. This study aims to find out whether new blood-based tests could help doctors detect cancer recurrence sooner and personalize follow-up care to improve survival and quality of life.
You likely qualify if…
You likely don't qualify if…
If you join the first part of the study, you will have blood samples taken before surgery, 4 weeks after surgery, and 6 months after surgery. If you qualify for the second part, you may be randomly assigned to either receive standard follow-up care with regular clinical visits and imaging, or follow-up care guided by blood test results — where the frequency of imaging depends on whether the blood tests show signs of recurrence. Either way, you will have regular clinic visits and imaging tests (CT scans and ultrasound) over up to 3 years.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Denmark